Data derived from most recent annual or quarterly report
Market Cap	4.45 Billion	Shares Outstanding	44.86 Million	Avg 30-day Volume	3.402 Million
P/E Ratio	0.0	Dividend Yield	0.0	EPS	-1.45
Price to Revenue	28.6538	Debt to Equity	1.3948	EBITDA	-54.16 Million
Price to Book Value	54.3886	Operating Margin	-70.3105	Enterprise Value	2.349 Billion
Current Ratio	6.289	EPS Growth	0.216	Quick Ratio	6.02
1 Yr BETA	1.6597	52-week High/Low	0.0 /	Profit Margin	-76.1397
Operating Cash Flow Growth	-436.6692	Altman Z-Score	9.9569	Free Cash Flow to Firm	-71.898 Million

Funds Holding ANAC1 (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANAC1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

3: filed on 2021-03-08 by GLAZER CAPITAL MANAGEMENT LP

3: filed on 2021-02-22 by COLLINS TOMAGO

3: filed on 2021-02-22 by GUTIERREZ XAVIER A

3: filed on 2021-02-22 by SMITH JARED T

3: filed on 2021-02-22 by MCPHERRON MEREDITH LAZO

3: filed on 2021-02-22 by ARCTOS NORTHSTAR ACQUISITION HOLDINGS, LLC

3: filed on 2021-02-22 by EPSTEIN THEO NATHANIEL

3: filed on 2021-02-22 by VEDRO JOHN BARNEY

3: filed on 2021-02-22 by CHARLES IAN HUNTER

3: filed on 2021-02-22 by OCONNOR DAVID JUSTIN

Events (8k)

8-K: filed on 2016-06-24:

Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2016-06-08:

Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2016-05-16:

Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2016-05-10:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2016-04-06:

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2016-04-01:

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2016-03-30:

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2016-03-22:

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2016-02-29:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2016-02-24:

Item 8.01: Other Events

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date
GLAZER CAPITAL, LLC GLAZER PAUL J	10% Owner	2,968,202	2021-02-23
COLLINS TOMAGO	Director	0	2021-02-22
GUTIERREZ XAVIER A	Director	0	2021-02-22
ARCTOS NORTHSTAR ACQUISITION HOLDINGS, LLC	10% Owner	0	2021-02-22
SMITH JARED T	Director	0	2021-02-22
EPSTEIN THEO NATHANIEL SEE REMARKS	Officer Director	0	2021-02-22
MCPHERRON MEREDITH LAZO	Director	0	2021-02-22
CHARLES IAN HUNTER	Director 10% Owner	0	2021-02-22
VEDRO JOHN BARNEY CHIEF FINANCIAL OFFICER	Officer	0	2021-02-22
OCONNOR DAVID JUSTIN SEE REMARKS	Officer Director 10% Owner	0	2021-02-22
LESCHLY MARK	Director	No longer subject to file	2016-06-24
RIEFLIN WILLIAM JL	Director	No longer subject to file	2016-06-24
BERNS PAUL L PRESIDENT AND CEO	Officer Director	No longer subject to file	2016-06-24
WIERENGA WENDALL	Director	No longer subject to file	2016-06-24
HOVE ANDERS D	Director	No longer subject to file	2016-06-24
LEONARD KEITH R	Director	No longer subject to file	2016-06-24
IPPOLITO VINCENT P EVP & CHIEF COMMERCIAL OFFICER	Officer	No longer subject to file	2016-06-24
SHAPIRO LUCY	Director	No longer subject to file	2016-06-24
ZANE LEE SVP AND CHIEF MEDICAL OFFICER	Officer	No longer subject to file	2016-06-24
SULLIVAN RYAN T EVP AND GENERAL COUNSEL	Officer	No longer subject to file	2016-06-24
BELL GRAEME EXECUTIVE VP AND CFO	Officer	No longer subject to file	2016-06-24
MAPLES KIRK R SVP, PROGRAM MANAGEMENT	Officer	7,220	2015-06-01
PLATTNER JACOB J SENIOR VP, RESEARCH	Officer	22,860	2015-05-15
RODRIGUEZ CARMEN R SNR VP REG AFRS & QUAL. ASSUR.	Officer	7,020	2015-05-12
CHANDA SANJAY SVP, DRUG DEVELOPMENT	Officer	29,087	2015-03-04
PARKER GEOFFREY M. EXECUTIVE VICE PRESIDENT & CFO	Officer	274,840	2015-02-03
KLINGENSTEIN PAUL H	Director	0	2014-05-29
PERRY DAVID P PRESIDENT AND CEO	Officer Director	361,306	2014-03-04
RHO VENTURES IV QP LP RHO VENTURES IV GMBH & CO BETEILIGUNGS KG RHO VENTURES IV HOLDINGS LLC RHO VENTURES IV LP RHO MANAGEMENT VENTURES IV LLC	10% Owner	No longer subject to file	2014-02-03
VENROCK ASSOCIATES IV L P VENROCK PARTNERS, L.P. VENROCK ENTREPRENEURS FUND IV L P VENROCK MANAGEMENT IV, LLC VENROCK PARTNERS MANAGEMENT, LLC VEF MANAGEMENT IV, LLC VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP CO-INVESTMENT HOLDINGS, LLC VHCP MANAGEMENT, LLC ROBERTS BRYAN E	10% Owner	3,575,535	2013-11-15
RHO VENTURES IV LP	10% Owner	243,815	2013-11-14
RHO VENTURES IV QP LP RHO VENTURES IV HOLDINGS LLC RHO VENTURES IV GMBH & CO BETEILIGUNGS KG RHO VENTURES IV LP RHO CAPITAL PARTNERS VERWALTUNGS GMBH RHO MANAGEMENT VENTURES IV LLC	10% Owner	4,371,423	2013-10-24
VENROCK ASSOCIATES V LP VENROCK PARTNERS V L P VENROCK MANAGEMENT V, LLC VENROCK PARTNERS MANAGEMENT V, LLC ROBERTS BRYAN E	10% Owner	3,725,535	2012-09-20
VENROCK ASSOCIATES IV L P VENROCK PARTNERS, L.P. VENROCK ENTREPRENEURS FUND IV L P VENROCK MANAGEMENT IV, LLC VENROCK PARTNERS MANAGEMENT, LLC VEF MANAGEMENT IV, LLC VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP CO-INVESTMENT HOLDINGS, LLC VHCP MANAGEMENT, LLC	10% Owner	3,725,535	2012-09-20
HEYMAN IRWIN A SENIOR VP, DRUG DEVELOPMENT	Officer	0	2012-03-13
RHO MANAGEMENT TRUST I	10% Owner	0	2011-12-20
RHO VENTURES IV HOLDINGS LLC	10% Owner	1,533,600	2011-12-20
MARKHAM RICHARD J	Director	0	2011-05-25
CARE CAPITAL INVESTMENTS II LP CARE CAPITAL OFFSHORE INVESTMENTS II LP	10% Owner	No longer subject to file	2010-11-30
VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP CO-INVESTMENT HOLDINGS, LLC VHCP MANAGEMENT, LLC ROBERTS BRYAN E	SEE FOOTNOTE 2SEE FOOTNOTE 2SEE FOOTNOTE 2SEE FOOTNOTE 2	2,000,000	2010-11-30
RHO VENTURES IV QP LP RHO VENTURES IV LP RHO MANAGEMENT TRUST I RHO VENTURES IV GMBH & CO BETEILIGUNGS KG RHO CAPITAL PARTNERS VERWALTUNGS GMBH RHO MANAGEMENT VENTURES IV LLC RUCH JOSHUA RHO CAPITAL PARTNERS INC KAIROUZ HABIB	10% Owner	0	2010-11-23
GLAXOSMITHKLINE PLC	10% Owner	1,771,374	2010-11-23
VENROCK ASSOCIATES IV L P VENROCK PARTNERS, L.P. VENROCK ENTREPRENEURS FUND IV L P VENROCK MANAGEMENT IV, LLC VENROCK PARTNERS MANAGEMENT, LLC VEF MANAGEMENT IV, LLC	10% Owner	0	2010-11-23
ABERDARE VENTURES II, L.P. ABERDARE VENTURES II (BERMUDA), L.P. ABERDARE II ANNEX FUND L P ABERDARE GP II, L.L.C.	10% Owner	0	2010-11-23
HONG ZHI	Director	0	2010-11-23

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Perf 1m*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security	Date/Time	Rebate Rate	Fee Rate	Shares Available

Current Active Short Positions

Holder	Issuer	Net Short Position	Position Date	Origin

Anacor Pharmaceuticals Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Anacor Pharmaceuticals Inc (ANAC1)

Funds Holding ANAC1 (via 13F filings)

Filter by:

Mutual Funds Holding ANAC1 BETA

Active Schedule 13D and 13G filings

Recent Filings

Financial Reporting

Ownership

Events (8k)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

IBR Securities Loan Availability

Current Active Short Positions

Elevate your investments